Stanley Druckenmiller – TEVA history
- Issuer:
- Teva Pharmaceutical Inds Ltd
- Quarters tracked:
- 7 (Q3 2024 → Q1 2026)
- Current shares:
- 2,377,285
- Current value:
- $71.60M
- Peak shares:
- 16,593,935 (Q3 2025)
- Overall change:
- +66%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 2,377,285 | $71.60M | $30.12 | -3,497,585 | -60% |
| Q4 2025 | 5,874,870 | $183.35M | $31.21 | -10,719,065 | -65% |
| Q3 2025 | 16,593,935 | $335.20M | $20.20 | +625,000 | +4% |
| Q2 2025 | 15,968,935 | $267.64M | $16.76 | +1,089,185 | +7% |
| Q1 2025 | 14,879,750 | $228.70M | $15.37 | +5,882,350 | +65% |
| Q4 2024 | 8,997,400 | $198.30M | $22.04 | +7,569,450 | +530% |
| Q3 2024 | 1,427,950 | $25.73M | $18.02 | — | NEW |